Donald J. Hayden Jr., Director at REGENXBIO Inc. (RGNX), sold 30,000 shares at $50.06 ($1.5M) on 2018-05-15, disclosed to the SEC on 2018-05-16.
Open-market sale of $1.5M RGNX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.04 | 5,153 | $258K | 17.2% |
| 2 | $50.04 | 5,153 | $258K | 17.2% |
| 3 | $50.06 | 9,847 | $493K | 32.8% |
| 4 | $50.06 | 9,847 | $493K | 32.8% |
| Total | $50.05 avg | 30,000 | $1.5M | 100% |
| Filing → |
| RGNX | SELL | 2020-02-07 | $100K | — | Filing → |
| RGNX | SELL | 2020-01-21 | $160K | — | Filing → |
| RGNX | SELL | 2020-01-16 | $1.4M | — | Filing → |